Acrux Limited Stock

Equities

ACR

AU000000ACR3

Pharmaceuticals

Market Closed - Australian S.E. 19:59:54 2024-05-02 EDT 5-day change 1st Jan Change
0.065 AUD 0.00% Intraday chart for Acrux Limited +1.56% +47.73%

Financials

Sales 2024 * 6.5M 4.31M 5.88M Sales 2025 * 12.3M 8.16M 11.12M Capitalization 18.9M 12.53M 17.09M
Net income 2024 * -3M -1.99M -2.71M Net income 2025 * 2M 1.33M 1.81M EV / Sales 2024 * 2.49 x
Net cash position 2024 * 2.7M 1.79M 2.44M Net cash position 2025 * 5.2M 3.45M 4.7M EV / Sales 2025 * 1.11 x
P/E ratio 2024 *
-5 x
P/E ratio 2025 *
8.13 x
Employees -
Yield 2024 *
-
Yield 2025 *
-
Free-Float 82.31%
More Fundamentals * Assessed data
Dynamic Chart
1 week+1.56%
Current month+35.42%
1 month+38.30%
3 months-7.14%
6 months+58.54%
Current year+47.73%
More quotes
1 week
0.06
Extreme 0.059
0.07
1 month
0.05
Extreme 0.047
0.10
Current year
0.05
Extreme 0.046
0.10
1 year
0.04
Extreme 0.035
0.10
3 years
0.04
Extreme 0.035
0.16
5 years
0.04
Extreme 0.035
0.32
10 years
0.04
Extreme 0.035
2.10
More quotes
Managers TitleAgeSince
Chief Executive Officer - 14-11-02
Director of Finance/CFO - 21-06-20
Chief Tech/Sci/R&D Officer - 15-02-14
Members of the board TitleAgeSince
Director/Board Member 68 16-05-31
Founder 72 97-12-31
Chief Executive Officer - 14-11-02
More insiders
Date Price Change Volume
24-05-02 0.065 0.00% 50 016
24-05-02 0.065 +3.17% 816,220
24-05-01 0.063 -8.70% 557,826
24-04-30 0.069 +13.11% 688,394
24-04-29 0.061 +1.67% 151,218

Delayed Quote Australian S.E., May 02, 2024 at 07:59 pm

More quotes
Acrux Limited is an Australia-based specialty pharmaceutical company. The Company is engaged in developing and commercializing a pipeline of topically applied pharmaceutical products. Its products include Lidocaine and Prilocaine Cream, USP 2.5%/2.5%, Lenzetto, Evamist and Testosterone Topical Solution, 30 mg / 1.5 ml. Lidocaine and Prilocaine Cream USP (a eutectic mixture of lidocaine 2.5% and prilocaine 2.5%) is indicated as a topical anesthetic for use on normal intact skin for local analgesia and genital mucous membranes for superficial minor surgery and as pretreatment for infiltration anesthesia. Lenzetto(estradiol 1.53 mg/spray, transdermal spray, solution) is an estradiol spray for women which is used to treat moderate to severe hot flushes commonly associated with menopause. Testosterone Topical Solution is indicated for replacement therapy in males for conditions associated with a deficiency or absence of endogenous testosterone.
More about the company

Annual profits - Rate of surprise